Denali Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
DNLI Key Statistics
Stock Snapshot
With a market cap of 2.65B, Denali Therapeutics(DNLI) trades at $16.95. The stock has a price-to-earnings ratio of -5.91.
During the trading session on 2026-01-07, Denali Therapeutics(DNLI) shares reached a daily high of $17.95 and a low of $16.70. At a current price of $16.95, the stock is +1.5% higher than the low and still -5.6% under the high.
Trading volume for Denali Therapeutics(DNLI) stock has reached 1.86M, versus its average volume of 1.25M.
Over the past 52 weeks, Denali Therapeutics(DNLI) stock has traded between a high of $24.35 and a low of $10.57.
Over the past 52 weeks, Denali Therapeutics(DNLI) stock has traded between a high of $24.35 and a low of $10.57.
DNLI News
Claim 70% Off TipRanks Premium Denali Therapeutics ( (DNLI) ) has provided an update. On January 6, 2026, Denali Therapeutics outlined its key priorities and...
Denali Therapeutics (DNLI) announced key anticipated milestones and priorities for 2026 across its portfolio of investigational therapies for neurodegenerative...